Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$798M |
| 2 |
AT&T
T
|
+$527M |
| 3 |
Microchip Technology
MCHP
|
+$472M |
| 4 |
Netflix
NFLX
|
+$446M |
| 5 |
PNC Financial Services
PNC
|
+$444M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$694M |
| 2 |
KeyCorp
KEY
|
+$401M |
| 3 |
Deere & Co
DE
|
+$322M |
| 4 |
CSX Corp
CSX
|
+$318M |
| 5 |
NXP Semiconductors
NXPI
|
+$314M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 5.93% |
| 2 | Technology | 4.66% |
| 3 | Healthcare | 4.45% |
| 4 | Industrials | 4.14% |
| 5 | Consumer Discretionary | 3.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
PUT
Royal Bank of Canada
RY
$301B
| $3.37M | ﹤0.01% |
42,000
-11,200
| -21% | -$878K |
|
3402
Immersion
IMMR
$249M
| $3.37M | ﹤0.01% |
318,438
+123,872
| +64% | +$1.55M |
|
3403
PUT
Weyerhaeuser
WY
$17.7B
| $3.36M | ﹤0.01% |
104,200
+17,400
| +20% | +$604K |
|
|
SRG
3404
PUT
Seritage Growth Properties
SRG
$128M
| $3.36M | ﹤0.01% |
70,800
+200
| +0.3% | +$9.48K |
|
3405
PUT
RingCentral
RNG
$5.39B
| $3.36M | ﹤0.01% |
36,100
+21,400
| +146% | +$1.85M |
|
|
MRSH
3406
PUT
Marsh
MRSH
$89.6B
| $3.36M | ﹤0.01% |
40,600
+4,000
| +11% | +$339K |
|
3407
Alamo Group
ALG
$2.01B
| $3.36M | ﹤0.01% |
36,639
+2,651
| +8% | +$249K |
|
3408
CALL
Factset
FDS
$10.1B
| $3.36M | ﹤0.01% |
15,000
-40,000
| -73% | -$8.68M |
|
|
CWEN.A
3409
DELISTED
Clearway Energy Class A
CWEN.A
| $3.35M | ﹤0.01% |
176,194
+8,051
| +5% | +$153K |
|
3410
CALL
Willis Towers Watson
WTW
$30.8B
| $3.35M | ﹤0.01% |
23,800
-5,000
| -17% | -$756K |
|
3411
PUT
Apollo Global Management
APO
$83.1B
| $3.35M | ﹤0.01% |
96,900
+40,400
| +72% | +$1.41M |
|
|
P
3412
PUT
Everpure Inc
P
$39.3B
| $3.35M | ﹤0.01% |
128,900
-128,800
| -50% | -$3.2M |
|
3413
KB Home
KBH
$3.44B
| $3.34M | ﹤0.01% |
139,568
-46,631
| -25% | -$1.17M |
|
3414
iShares US Consumer Staples ETF
IYK
$1.44B
| $3.33M | ﹤0.01% |
84,171
+25,464
| +43% | +$1.02M |
|
3415
Zumiez
ZUMZ
$314M
| $3.33M | ﹤0.01% |
126,481
+41,009
| +48% | +$1.08M |
|
|
CLVS
3416
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
| $3.33M | ﹤0.01% |
113,300
+23,300
| +26% | +$902K |
|
|
VAR
3417
CALL
DELISTED
Varian Medical Systems, Inc.
VAR
| $3.32M | ﹤0.01% |
29,700
+15,000
| +102% | +$1.7M |
|
3418
PUT
Coty
COTY
$2.51B
| $3.32M | ﹤0.01% |
264,300
-24,700
| -9% | -$320K |
|
|
3419
CALL
Royal Bank of Canada
RY
$301B
| $3.32M | ﹤0.01% |
41,400
-14,000
| -25% | -$1.1M |
|
|
UN
3420
PUT
DELISTED
Unilever NV New York Registry Shares
UN
| $3.32M | ﹤0.01% |
59,700
+18,400
| +45% | +$1.04M |
|
|
ARRY
3421
CALL
DELISTED
Array Biopharma Inc
ARRY
| $3.31M | ﹤0.01% |
218,100
-7,200
| -3% | -$110K |
|
3422
CALL
Ovintiv
OVV
$17.4B
| $3.31M | ﹤0.01% |
50,560
-8,960
| -15% | -$581K |
|
|
ADAP
3423
DELISTED
Adaptimmune Therapeutics
ADAP
| $3.31M | ﹤0.01% |
244,289
+131,009
| +116% | +$1.37M |
|
3424
CALL
LivaNova
LIVN
$4.53B
| $3.31M | ﹤0.01% |
26,700
+6,700
| +34% | +$790K |
|
3425
CALL
EPAM Systems
EPAM
$5.18B
| $3.31M | ﹤0.01% |
24,000
+11,300
| +89% | +$1.52M |
|
Similar funds
Ken Griffin's Q3 2018 Portfolio in Review
As of Q3 2018, Ken Griffin held 10,190 positions worth $224B, up 10% from $203B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ken Griffin deployed $7.48B of net new capital in Q3 2018, opening 1,427 new positions and adding to 4,227 existing holdings. Its largest new stake was Alibaba: 1,030,311 shares worth $170M.
By sector, the portfolio is most concentrated in Financials at 5.9% of assets, down from 6.2% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Goldman Sachs, an estimated $694M trimmed.
- Ken Griffin's largest Q3 2018 buy was Alibaba: 1,030,311 shares worth $170M.
- Ken Griffin added most to Morgan Stanley in Q3 2018, an estimated $798M increase.
- Ken Griffin's biggest Q3 2018 reduction was Goldman Sachs, cutting an estimated $694M.
- Ken Griffin fully exited XL Group Ltd. in Q3 2018, selling an estimated $207M.
- Ken Griffin's ten largest holdings make up 25% of its $224B portfolio in Q3 2018.
- Ken Griffin opened 1,427 new positions and closed 1,043 in Q3 2018.
- Ken Griffin's portfolio value rose 10% quarter-over-quarter to $224B.
Based on Citadel Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.